Torigen recently published an article entitled “Equine Immuno-Oncology Gallops Ahead” in the Midwest Grazer Spring/Summer 2024 magazine ..read more

We recently had a chance to interview Christie, our External Innovation & Clinical Trials Manager! She gives us some insight into her role at Torigen ..read more

2023 has been a year of growth and success for Torigen, and we are happy to be reflecting on it ..read more

, 1 in 4 dogs and 1 in 5 cats will develop cancer in their lifetimes. Thankfully, veterinarians suggest that many forms of cancer can be put into remission with early and appropriate intervention ..read more

Torigen started as just an idea that was forged from grit, elbow-grease, novel technology and spun out of the University of Notre Dame into a company focused on helping animals with cancer. To me, Torigen is so much more. At one point, Torigen didn’t exist. Just like Google, Amazon or Pfizer, brands that we all recognize as industry game-changers, we started with just a technology and a dream ..read more

Are you proud to offer Torigen’s Experimental Autologous Prescription Product in your practice but not sure how to share the news with your customers? We have a solution ..read more

..read more

We recently had a chance to interview Kelly, one of our technicians who processes the vaccines! She gives us some insight into what a typical day looks like as a technician at Torigen ..read more

For veterinarians, it is important to share the warning signs of cancer in cats to help get more of our feline friends treated earlier ..read more

2022 was an amazing year at Torigen filled with continued growth and success ..read more